Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients
- 14 September 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 75 (11), 1015-1021
- https://doi.org/10.1212/wnl.0b013e3181f25b16
Abstract
Objectives: To test the hypothesis that neuropsychiatric symptomatology is predictive of the success of seizure control in patients newly treated with antiepileptic drugs (AEDs), and that this predictive value adds to that provided by other clinical, imaging, and genomic factors in a multivariate model. Methods: One hundred seventy newly treated patients with epilepsy completed the A-B Neuropsychological Assessment Scale (ABNAS) before commencing AED therapy and were prospectively followed up for 12 months. Patients were classified as nonresponsive if they had at least 1 seizure not explained by medication noncompliance or other significant provoking factors. Results: Of the 138 patients in whom a drug response phenotype at 12 months was able to be determined, nonresponsive patients (n = 45) had a higher pretreatment ABNAS score than patients whose seizures were controlled (n = 93) (p = 0.007). A lesion on MRI was also associated with a higher risk of seizure recurrence (p = 0.003). On multivariate logistic regression, the ABNAS score, the MRI results, and a genomic classifier were all independently predictive of treatment outcome. For AED pharmacoresponse, this multivariate model had diagnostic values of 91% sensitivity, 64% specificity, 84% positive predictive, and 78% negative predictive values. The predictive value of the ABNAS score was validated in a second prospective cohort of 74 newly treated patients with epilepsy (p = 0.005). Conclusions: The ABNAS provides prognostic information regarding successful seizure control in patients newly treated with AEDs. Furthermore, these results demonstrate the multifactorial nature of the determinants of AED response, with neuropsychological, structural, and genomic factors all contributing to the complex response phenotype.Keywords
This publication has 33 references indexed in Scilit:
- Multi-SNP pharmacogenomic classifier is superior to single-SNP models for predicting drug outcome in complex diseasesPharmacogenetics and Genomics, 2009
- Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causationExperimental Neurology, 2008
- The Liverpool Adverse Events Profile: Relation to AED Use and MoodEpilepsia, 2007
- Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort studyThe Lancet Neurology, 2006
- Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trialThe Lancet Neurology, 2006
- Anxiety in Rats Selectively Bred for Fast and Slow Kindling Rates: Situation-Specific OutcomesStress, 2003
- Psychiatric Outcome After Temporal Lobectomy: A Predictive StudyEpilepsia, 2000
- Major depression is a risk factor for seizures in older adultsAnnals of Neurology, 2000
- Proposal for Revised Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1989
- The Prognosis for Seizure Control in Newly Diagnosed EpilepsyThe New England Journal of Medicine, 1984